Neurotrophin-3 Sorts to the Constitutive Secretory Pathway of Hippocampal Neurons and Is Diverted to the Regulated Secretory Pathway by Coexpression with Brain-Derived Neurotrophic Factor

Hippocampal neurons release nerve growth factor (NGF) through the constitutive secretory pathway, thus allowing the protein to be continuously available for promoting nerve cell survival. In contrast, hippocampal neurons use the regulated secretory pathway to process brain-derived neurotrophic factor (BDNF), which alters synaptic activity when released acutely from dense-core vesicles. Thus, understanding how neurons sort and deliver neurotrophins may provide clues to their functions in brain. In this study, we monitored the processing and delivery of neurotrophin-3 (NT-3). Pulse–chase studies, immunocytochemistry, and secretagogue-induced release experiments were performed on cultured hippocampal neurons and AtT-20 cells infected with vaccinia viruses encoding the NT-3 precursor (pro-NT-3). Results show that most newly synthesized NT-3 is released through the constitutive secretory pathway as a result of furin-mediated endoproteolytic cleavage of pro-NT-3 in the trans-Golgi network. Pro-NT-3 can also be diverted into the regulated secretory pathway when cells are treated with α1-PDX, a selective inhibitor of furin-like enzymes, or when pro-NT-3 expression is increased by transient transfection methods. In cells coinfected with viruses coding for pro-NT-3 and pro-BDNF, NT-3 is sorted into the regulated pathway, stored in secretory granules, and released in response to extracellular cues together with BDNF, apparently as a result of heterodimerization, as suggested by coimmunoprecipitation data. Taken together, these data show that sorting of the NT-3 precursor can occur in both the constitutive and regulated secretory pathways, which is consistent with NT-3 having both survival-promoting and synapse-altering functions.

[1]  T. Takeuchi,et al.  Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the non‐endocrine cell line, COS‐7 , 1992, FEBS letters.

[2]  W. Rutter,et al.  Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector , 1988, Molecular and cellular biology.

[3]  R. Kelly,et al.  Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation , 1983, Cell.

[4]  A. Konnerth,et al.  Neurotrophin-evoked rapid excitation through TrkB receptors , 1999, Nature.

[5]  E. Schuman,et al.  Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus , 1995, Science.

[6]  N. Seidah,et al.  Comparative cellular processing of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp160 by the mammalian subtilisin/kexin-like convertases. , 1996, The Biochemical journal.

[7]  J. Culvenor,et al.  Overexpression of beta 2-microglobulin in transgenic mouse islet beta cells results in defective insulin secretion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Treanor,et al.  Heterodimeric Neurotrophins Induce Phosphorylation of Trk Receptors and Promote Neuronal Differentiation in PC12 Cells (*) , 1995, The Journal of Biological Chemistry.

[9]  E. Shooter,et al.  The Regulated Secretion and Vectorial Targeting of Neurotrophins in Neuroendocrine and Epithelial Cells* , 1996, The Journal of Biological Chemistry.

[10]  Y. Barde,et al.  Brain‐Derived Neurotrophic Factor Levels in the Nervous System of Wild‐Type and Neurotrophin Gene Mutant Mice , 1999, Journal of neurochemistry.

[11]  J. Baxter,et al.  A Protease Processing Site Is Essential for Prorenin Sorting to the Regulated Secretory Pathway* , 1996, The Journal of Biological Chemistry.

[12]  L. Belluscio,et al.  NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression , 1990, Neuron.

[13]  D. Holtzman,et al.  Nerve growth factor and the neurotrophic factor hypothesis , 1996, Brain and Development.

[14]  T. Bonhoeffer,et al.  Relative Contribution of Endogenous Neurotrophins in Hippocampal Long-Term Potentiation , 1999, The Journal of Neuroscience.

[15]  K. Howell,et al.  Identification, sequencing and expression of an integral membrane protein of the trans-Golgi network (TGN38). , 1990, The Biochemical journal.

[16]  M. Ikeda,et al.  Sequence requirements for proteolytic cleavage of precursors with paired basic amino acids. , 1991, Biochemical and biophysical research communications.

[17]  T. Watanabe,et al.  Sequence requirements for precursor cleavage within the constitutive secretory pathway. , 1992, The Journal of biological chemistry.

[18]  N. Seidah,et al.  α1-Antitrypsin Portland Inhibits Processing of Precursors Mediated by Proprotein Convertases Primarily within the Constitutive Secretory Pathway* , 1997, The Journal of Biological Chemistry.

[19]  Howard J. Federoff,et al.  Regulated Release and Polarized Localization of Brain-Derived Neurotrophic Factor in Hippocampal Neurons , 1996, Molecular and Cellular Neuroscience.

[20]  D. Stuart,et al.  Structure of the brain-derived neurotrophic factor/neurotrophin 3 heterodimer. , 1995, Biochemistry.

[21]  N. Seidah,et al.  Precursor Convertases: An Evolutionary Ancient, Cell‐Specific, Combinatorial Mechanism Yielding Diverse Bioactive Peptides and Proteins , 1998, Annals of the New York Academy of Sciences.

[22]  L. Parada,et al.  Neuronal NT-3 is not required for synaptic transmission or long-term potentiation in area CA1 of the adult rat hippocampus. , 1999, Learning & memory.

[23]  M. Bielińska,et al.  Human luteinizing hormone and chorionic gonadotropin are targeted to a regulated secretory pathway in GH3 cells. , 1994, Molecular endocrinology.

[24]  R. A. Murphy,et al.  Detection of Brain-derived Neurotrophic Factor in a Vesicular Fraction of Brain Synaptosomes* , 1997, The Journal of Biological Chemistry.

[25]  Y. Barde,et al.  Purification and characterisation of a brain-derived neurotrophic factor/neurotrophin-3 (BDNF/NT-3) heterodimer. , 1994, European journal of biochemistry.

[26]  M Chrétien,et al.  Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. , 1996, The Biochemical journal.

[27]  H. Naim.  Dimerization of lactase-phlorizin hydrolase occurs in the endoplasmic reticulum, involves the putative membrane spanning domain and is required for an efficient transport of the enzyme to the cell surface. , 1996, European journal of cell biology.

[28]  L. Thomas,et al.  Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant. , 1993, The Journal of biological chemistry.

[29]  Q. Yan,et al.  Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system , 1997, Neuroscience.

[30]  T Bonhoeffer,et al.  Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  An Zhou,et al.  Proteolytic Processing in the Secretory Pathway* , 1999, The Journal of Biological Chemistry.

[32]  E. Shooter,et al.  The Biosynthesis of Neurotrophin Heterodimers by Transfected Mammalian Cells (*) , 1995, The Journal of Biological Chemistry.

[33]  W. Maxwell Cowan,et al.  Rat hippocampal neurons in dispersed cell culture , 1977, Brain Research.

[34]  C. Altar,et al.  Neurotrophin trafficking by anterograde transport , 1998, Trends in Neurosciences.

[35]  T. Arakawa,et al.  Interactions of neurotrophin-3 (NT-3), brain-derived neurotrophic factor (BDNF), and the NT-3.BDNF heterodimer with the extracellular domains of the TrkB and TrkC receptors. , 1994, The Journal of biological chemistry.

[36]  J. Baenziger,et al.  Differential sorting of lutropin and the free alpha-subunit in cultured bovine pituitary cells. , 1992, The Journal of biological chemistry.

[37]  R. Scheller,et al.  Peptide processing and targeting in the neuronal secretory pathway. , 1991, Science.

[38]  M. Bothwell,et al.  Novel roles for neurotrophins are suggested by BDNF and NT-3 mRNA expression in developing neurons , 1992, Neuron.

[39]  E. Shooter,et al.  Subcellular localization of epitope‐tagged neurotrophins in neuroendocrine cells , 1998, Journal of neuroscience research.

[40]  L C Katz,et al.  Neurotrophins and synaptic plasticity. , 1999, Annual review of neuroscience.

[41]  N. Seidah,et al.  Differential Sorting of Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Hippocampal Neurons , 1999, The Journal of Neuroscience.

[42]  J. Miller,et al.  Formation of heterodimers from three neurotrophins, nerve growth factor, neurotrophin-3, and brain-derived neurotrophic factor. , 1994, The Journal of biological chemistry.

[43]  R. Lindsay,et al.  The NeurotroDhins BDNF, NT‐3 and NT‐4/5 Promote Survival and Morphological and Biochemical Differentiation of Striatal Neurons In Vitro , 1995, The European journal of neuroscience.

[44]  J. Culvenor,et al.  Overexpression of .82-microglobulin in transgenic mouse islet f8 cells results in defective insulin secretion , 2022 .

[45]  G. Michael,et al.  Nerve Growth Factor Treatment Increases Brain-Derived Neurotrophic Factor Selectively in TrkA-Expressing Dorsal Root Ganglion Cells and in Their Central Terminations within the Spinal Cord , 1997, The Journal of Neuroscience.

[46]  A. Sadikot,et al.  Evidence that Brain-Derived Neurotrophic Factor from Presynaptic Nerve Terminals Regulates the Phenotype of Calbindin-Containing Neurons in the Lateral Septum , 2000, The Journal of Neuroscience.

[47]  E. Danielsen.  Perturbation of intestinal microvillar enzyme biosynthesis by amino acid analogs. Evidence that dimerization is required for the transport of aminopeptidase N out of the endoplasmic reticulum. , 1990, The Journal of biological chemistry.

[48]  G. Brewer,et al.  Optimized survival of hippocampal neurons in B27‐supplemented neurobasal™, a new serum‐free medium combination , 1993, Journal of neuroscience research.

[49]  G. Thomas,et al.  Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus , 1995, Journal of virology.

[50]  R. Robinson,et al.  Heterodimers of the neurotrophic factors: formation, isolation, and differential stability. , 1993, Biochemistry.

[51]  N. Seidah,et al.  Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases , 1996, FEBS letters.

[52]  R. A. Murphy,et al.  Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cells: Inhibition by antibodies to NGF , 1991, Neuron.

[53]  J. Ruysschaert,et al.  The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM). , 1994, The Journal of biological chemistry.

[54]  P. Barker,et al.  Immunological relationships of NGF, BDNF, and NT-3: recognition and functional inhibition by antibodies to NGF , 1993, Journal of Neuroscience.